A great medical success is the increase in the median survival age associated with cystic fibrosis (CF). However, this success...
SP2086 is a new dipeptidy1 peptidase(DPP)-4 inhibitors. This study aims to evaluate the efficacy and safety of SP2086 as monotherapy...
Investigators will be determining whether a once weekly injectable medication Bydureon versus placebo is able to reduce the development of...
This is a double-blind, randomized , placebo-controlled study to evaluate the safety and tolerability of AVT001, and to assess AVT001...
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of the study drug dulaglutide compared...
This is a Phase 1 study designed to assess the safety and tolerability of MEDI0382 (Cotadutide) in Japanese T2DM patients.
Primary Objective: To demonstrate the noninferiority of insulin glargine 300 U/mL in comparison to insulin ...
The phase III trial is designed with an aim of determining the efficacy of Investigational Product TRC150094 in concurrently reducing...
This is a randomized, placebo-controlled, double-blind study to evaluate the efficacy, safety, and pharmacodynamics (PD) of multiple doses of REMD-477...
This study is comparing the effect of a long-acting insulin analogue (insulin 287) with insulin glargine (Lantus®) in subjects with...
The purpose of this study is to assess the effect of canagliflozin relative to placebo on glycated hemoglobin (HbA1c) after...
The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin...
The purpose of this research study is to evaluate the efficacy and safety of the drugs dapagliflozin and saxagliptin in...
Primary Objective: To demonstrate that the simple daily titration algorithm is non-inferior to the weekly ...
The purpose of this study is to investigate the effects of 5 weeks treatment with dapagliflozin in type 2 diabetes...
This study will evaluate the safety and efficacy of Relamorelin compared to placebo in patients with diabetic gastroparesis. Patients will...
A 52-week study to compare the efficacy of relamorelin with that of placebo in participants with diabetic gastroparesis (DG) with...
The purpose of this research study is to determine if rifampin, an antibiotic (a medicine that treats infections), is effective...
English (USA)